7 unchanged sentences
On April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to repurchase up to $600 million of shares of our common stock of the $1.2 billion shares authorized.
−Removed: As of June 30, 2021, we have repurchased approximately 3.4 million shares of common stock for $184.5 million, or $54.71 per share, under the plan.
−Removed: In total, as of June 30, 2021, we have repurchased 10.5 million common shares for $529.0 million under the Repurchase Program.
+Added: As of September 30, 2021, we have repurchased approximately 8.7 million shares of common stock for $438.9 million, or $50.57 per share, under the plan.
+Added: In total, as of September 30, 2021, we have repurchased 15.8 million shares of common stock for $783.4 million, or $49.58 per share, under the Repurchase Program.
+Added: On October 5, 2021, we terminated our Rule 10b5-1 share repurchase plan and on October 13, 2021 we entered into a Rule 10b-18 repurchase plan that allows us to conduct open market repurchases over time up to our remaining authorization under the Repurchase Program.
The amount and timing of share repurchases are subject to capital availability, our cash balances and future capital requirements and our determination that share repurchases are in the best interest of our stockholders and are in compliance with all respective laws and our applicable agreements.
−Removed: The table below summarizes the repurchases made under our Repurchase Program during the three months ended June 30, 2021:
+Added: We have paused our share repurchases and for the foreseeable future, we expect that our capital allocation will be prioritized towards opportunities to accelerate programs in our development pipeline and/or pursue potential complementary business development opportunities.
+Added: The table below summarizes the repurchases made under our Repurchase Program during the three months ended September 30, 2021:
Issuer Purchases of Equity Securities
7 unchanged sentences
(in millions)
−Removed: April 1, 2021 through April 30, 2021
+Added: July 1, 2021 through July 31, 2021
1,808,409 $ 53.20 1,808,409 $ 574.8
−Removed: May 1, 2021 through May 31, 2021
+Added: August 1, 2021 through August 31, 2021
2,719,340 $ 44.97 2,719,340 $ 452.5
−Removed: June 1, 2021 through June 30, 2021 243,410 $ 55.89 243,410 $ 671.0
+Added: September 1, 2021 through September 30, 2021 778,435 $ 46.12 778,435 $ 416.6
5,306,184 $ 47.94 5,306,184
−Removed: (1) All shares repurchased by us during the three months ended June 30, 2021 were repurchased pursuant to the Repurchase Program, as described above.
+Added: (1) All shares repurchased by us during the three months ended September 30, 2021 were repurchased pursuant to the Repurchase Program, as described above.
Incorporated by Reference
5 unchanged sentences
December 19, 2018 3.1
+Added: 10.1# Letter Agreement, dated as of July 27, 2021, between the Registrant and Chris Bowden, M.D.
+Added: 10.2 Sublease Agreement, dated July 27, 2021, between the Registrant and Prime Medicine, Inc.
+Added: (38 Sidney Street)
31.1 Certification of principal executive officer pursuant to Rule 13a 14(a)/15d 14(a) of the Securities Exchange Act of 1934, as amended
11 unchanged sentences
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS) X
+Added: # Indicates management contract or compensatory plan or arrangement
* This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liability of that section.
2 unchanged sentences
AGIOS PHARMACEUTICALS, INC.
−Removed: July 29, 2021 By:
+Added: November 3, 2021 By:
/s/ Jacqualyn A.
1 unchanged sentence
(principal executive officer)
−Removed: July 29, 2021 By:
+Added: November 3, 2021 By:
/s/ Jonathan Biller
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.